Harbin Pharmaceutical Group Holding Company Overview
Founded
1989
Status
Public
Employees
3,424
Stock Symbol
600829
Investments
3
Share Price
$1.04
(As of Tuesday Closing)
Harbin Pharmaceutical Group Holding Company General Information
Description
HPGC Renmintongtai Pharmaceutical Corp, formerly Harbin Pharm. Group Sanjing Pharmaceutical Shareholding Co Ltd is engaged in the production and sale of pharmaceuticals products in China.
Contact Information
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Distributors/Wholesale
Stock Exchange
SHG
Primary Office
- Number 109 Xue Fu Road
- Harbin City, Nangang District 150086
- China
+86 0451 0000 0000
Harbin Pharmaceutical Group Holding Company Stock Performance
(As of Tuesday closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $1.04 | $1.05 | $0.81 - $1.65 | $604M | 580M | 10M | $0.06 |
Harbin Pharmaceutical Group Holding Company Financials Summary
|
In Thousands, USD |
TTM 31-Mar-2020 | FY 2019 31-Dec-2019 | FY 2018 31-Dec-2018 | FY 2017 31-Dec-2017 |
|---|---|---|---|---|
| EV | 581,561 | 571,010 | 482,248 | 1,069,813 |
| Revenue | 1,186,280 | 1,209,145 | 1,066,504 | 1,185,105 |
| EBITDA | 52,080 | 58,582 | 55,816 | 57,293 |
| Net Income | 34,759 | 38,694 | 38,979 | 37,614 |
| Total Assets | 777,322 | 792,837 | 641,424 | 741,557 |
| Total Debt | 82,838 | 74,891 | 32,563 | 34,310 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Harbin Pharmaceutical Group Holding Company Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
This information is available in the PitchBook Platform. To explore Harbin Pharmaceutical Group Holding Company‘s full profile, request access.
Request a free trial
Harbin Pharmaceutical Group Holding Company Competitors (1)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| 00000 000000000 00 | Corporation | Hong Kong, Hong Kong | 00000 |
Harbin Pharmaceutical Group Holding Company Executive Team (2)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Lijun Zhang | Chairman & General Manager | ||
| Chang Sun | Director |
Harbin Pharmaceutical Group Holding Company Board Members (1)
| Name | Representing | Role | Since |
|---|---|---|---|
| 00000 00000 | Harbin Pharmaceutical Group Holding Company | Chairman & General Manager | 000 0000 |
Harbin Pharmaceutical Group Holding Company Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
This information is available in the PitchBook Platform. To explore Harbin Pharmaceutical Group Holding Company‘s full profile, request access.
Request a free trial
Harbin Pharmaceutical Group Holding Company Investments & Acquisitions (3)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 0000000 000000 000 | 13-Feb-2019 | 00000 0000000 | Distributors/Wholesale | ||
| 0000000 000000000 | 13-Feb-2019 | 0000 | 00000 | Specialty Retail | 00000 00000 |
| Pfizer(swine vaccine business) | 31-May-2010 | Merger/Acquisition | 0000 | Drug Delivery |
Ready to get started?
Request a free trial